Clinical TrialsSearch results
Number of results: 500
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)
- Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation
- Nunomura Masaki
- 2022-09-28
Other
- Randomiszd phase III trial of adjuvant chemotherapy with gemcitabine vs. S-1 in patients with resected pancreatic cancer
- Resected pancreatic cancer
- Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC)
- 2007-04-01
Other
- Multi-Center Phase II Study on Efficacy of High-Slip Skin Care Pad for Hand-Foot Skin Reaction Caused by Sorafenib in Patients with Renal Cell Carcinoma
- Renal cell carcinoma
- Japanese Society of Renal Cancer (JSRC)
- 2009-05-29
Other
- Multi-institute randomized study of natural type interferon alpha for patients with renal cell carcinoma after radical nephrectomy
- Renal cell carcinoma
- TRAIn-Alpha study group
- 2005-09-30
Other
- RCC-SNPs Ensuring-study for Leading Eligibility of patients in Cytokine Therapy
- Renal cell carcinoma
- JISG-KC
- 2007-06-04
Other
- A combination phase I/II study of topotecan with carboplatin for relapsed small cell lung cancer
- relapsed small cell lung cancer
- West Japan Oncology Group
- 2005-09-07
Other
- Phase II study of erlotinib monotherapy for relapsed patients with non-small-cell lung cancer who do not possess any active EGFR gene mutations
- relapsed non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2008-11-16
Other
- Phase II study of irinotecan and amrubicin for relapsed non-small-cell lung cancer
- Relapsed non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase II Clinical Trial to test efficacy and safety of relapsed APL (JALSG APL205R study)
- relapsed acute promyelocytic leukemia (APL)
- Japan adult leukemia study group ( JALSG)
- 2005-12-30
Other
- Randomised controlled trial of multiple drugs combined therapy for diffuse IgA nephropathy
- Refractory IgA nephropathy
- Japanese Study Group of Multiple drug therapy for IgAN
- 2006-03-31